Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 12, 2024Experimental Hematology and OncologyOpen Access

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJunli LuChinese Academy of Medical Sciences & Peking Union Medical CollegeYLYiming LuoXiamen UniversityDRDean RaoTongji Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lu et al. (2024) studied this question.

synapsesocial.com/papers/68e6f4d2b6db64358766fe5dhttps://doi.org/10.1186/s40164-024-00505-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells2019 · 177 citations
  2. 2STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation2016 · 214 citations
  3. 3MIF: metastasis/MDSC-inducing factor?2013 · 26 citations
  4. 4METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer2022 · 302 citations
  5. 5Evidence‐based treatment of early‐stage melanoma2011 · 93 citations